Helen M Boudreau
CIK 1661481 · Chief Financial Officer · last filed 2026-06-02
Helen M Boudreau is a Chief Financial Officer who has filed 26 SEC Form 4 insider transactions across 5 companies since 2016. The most recent filing, for STTK, was dated Jun 2, 2026. Across all open-market trades the lifetime net is −$230.9K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
5
26
-$230.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| STTK | Director | — | $4.94 | — | $0 | 7 | 2026-06-02 |
| PINC | Director | 0 | $50.16 | $0 | -$230.9K | 9 | 2025-11-26 |
| RLYB | Director | — | $15.92 | — | $0 | 4 | 2025-05-15 |
| Tvardi Therapeutics, Inc. (CARA) Delisted | Director | 150,647 | $15.96 | $2.40M | $0 | 2 | 2024-06-06 |
| KINETA, INC./DE (PTI) Delisted | Chief Financial Officer | — | — | — | $0 | 4 | 2018-03-05 |
Recent Filings
26 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-02 | STTK | Grant (A) | — | $0 | EDGAR |
| 2025-11-26 | PINC | Disp (D) | −18,668 | -$527.4K | EDGAR |
| 2025-07-16 | STTK | Grant (A) | — | $0 | EDGAR |
| 2025-06-02 | PINC | Sell (S) | −2,000 | -$45.8K | EDGAR |
| 2025-05-15 | RLYB | Grant (A) | — | $0 | EDGAR |
| 2025-01-07 | PINC | Sell (S) | −2,500 | -$53.6K | EDGAR |
| 2024-12-10 | PINC | Grant (A) | +7,101 | $0 | EDGAR |
| 2024-06-21 | STTK | Grant (A) | — | $0 | EDGAR |
| 2024-06-06 | Tvardi Therapeutics, Inc. (CARA) Delisted | Grant (A) | +150,647 | $0 | EDGAR |
| 2024-05-17 | RLYB | Grant (A) | — | $0 | EDGAR |